A Bioluminescent Adenosine Nucleotide Release Assay for the Diagnosis of Heparin-Induced Thrombocytopenia

Thromb Haemost 1996; 76(03): 479
DOI: 10.1055/s-0038-1650606

Letters to the Editor

Schattauer GmbH Stuttgart

J M Teitel

The Department of Medicine, Division of Hematology, St. Michael’s Hospital, Toronto, and the University of Toronto, Toronto, Ontario, Canada

,

P Gross

The Department of Medicine, Division of Hematology, St. Michael’s Hospital, Toronto, and the University of Toronto, Toronto, Ontario, Canada

,

P Blake

The Department of Medicine, Division of Hematology, St. Michael’s Hospital, Toronto, and the University of Toronto, Toronto, Ontario, Canada

,

M B Garvey

The Department of Medicine, Division of Hematology, St. Michael’s Hospital, Toronto, and the University of Toronto, Toronto, Ontario, Canada

References
1 Warkentin TE, Kelton JG. Heparin-induced thrombocytopenia. Annu Rev Med 1989; 40: 31-44
2 Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93: 81-88
3 Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM. et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases. Thromb Haemost 1995; 73: 21-28
4 Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 27-30
5 Stewart MW, Etches WS, Boshkov LK, Gordon PA. Heparin-induced thrombocytopenia: An improved method of detection based on lumi-aggre-gometry. Br J Haematol 1995; 91: 173-177